SPP1 and congenital bilateral aplasia of vas deferens from CFTR mutation: In addition, we further identified that SPP1 was positively correlated with various immune cells (Figure 10c), suggesting that SPP1 holds a high possibility of serving as a target for the treatment of CAVD and OA.